Haptic Feedback for Improved Interoceptive Awareness and Mental Well-being
8 septembre 2026 mis à jour par: Massachusetts Institute of Technology
Haptic Feedback for Improved Interoceptive Awareness and Mental Well-being: A Comprehensive In-the-Wild Study for Wellness
This study investigates the relationship between heart-beat haptic feedback on interoceptive awareness and mental-wellbeing.
Previous research showed non-significant results in short-term emotion regulation tasks when given heartbeat haptic feedback, suggesting the need for an extended adjustment training period to build trust with interoceptive feedback systems.
To address this, the experimenters propose an in-the-wild study where participants wear a Bangle.js
smartwatch for one week each under two conditions: (1) Real heartbeat feedback and (2) Off-set heartbeat feedback.
This design aims to examine the influence of haptic feedback on psychological characteristics, including alexithymia, anhedonia, depression, anxiety, and general mental health.
The experimenters will also explore the usability and comfort levels related to prolonged wearable use, as well as the participants' ability to distinguish between real and off-set heartbeat feedback, particularly across different levels of alexithymia traits.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Réel)
29
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Massachusetts
-
Cambridge, Massachusetts, États-Unis, 02142
- MIT Media Lab
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Oui
La description
Inclusion Criteria:
- High alexithymia score at screening (TAS-20 >= 50)
Exclusion Criteria:
- Severe psychiatric condition
- Any type of heart arrythmia
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Real heartrate feedback
Participants wear a smartwatch during all waking hours which delivers vibration pulses at a frequency matching the current heart rate sensed by the smartwatch
|
Participants wear a smartwatch during their waking hours which delivers pulses of vibration which can be matched to the frequency of the current heart rate (real condition) or heart rate from one hour ago (sham condition)
|
|
Comparateur factice: Sham heartrate feedback
Participants wear a smartwatch during all waking hours which delivers vibration pulses at a frequency matching the heart rate from one hour ago as measured by the smartwatch.
The time delay means that feedback does not match the current heartrate but maintains the overall descriptive statistics of the participant's heartbeat.
|
Participants wear a smartwatch during their waking hours which delivers pulses of vibration which can be matched to the frequency of the current heart rate (real condition) or heart rate from one hour ago (sham condition)
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Center for Epidemiological Studies-Depression Scale
Délai: Difference from measurement at the start of each arm to end of each arm (1 week span)
|
Measured by the standard scoring procedure in each lab visit at the start of the week.
Decrease is considered an improvement.
|
Difference from measurement at the start of each arm to end of each arm (1 week span)
|
|
Interoceptive accuracy
Délai: 1 week (difference between SensHB at the start of each arm and the end of each arm)
|
Interoceptive accuracy measured using SensHb (slope of the correlation of estimated heart rate with smartwatch-recorded heart rate measured over three 1-minute measurement periods during the in-lab questionnaire)
|
1 week (difference between SensHB at the start of each arm and the end of each arm)
|
|
Snaith-Hamilton Pleasure Scale
Délai: Difference from measurement at the start of each arm to end of each arm (1 week span)
|
Measured at the lab visit at the start of each week.
We sum the pleasure rating for each item so the score represents overall hedonic capacity (opposite of anhedonia).
Increase is considered improvement
|
Difference from measurement at the start of each arm to end of each arm (1 week span)
|
|
General Anxiety Disorder-7 Anxiety Scale
Délai: Difference from measurement at the start of each arm to end of each arm (1 week span)
|
Measured by the standard scoring procedure in each lab visit at the start of the week.
Decrease is considered an improvement.
|
Difference from measurement at the start of each arm to end of each arm (1 week span)
|
|
Toronto Alexithymia Scale-20 Alexithymia Scale
Délai: Difference from measurement at the start of each arm to end of each arm (1 week span)
|
Measured by the standard scoring procedure in each lab visit at the start of the week.
Decrease is considered an improvement.
|
Difference from measurement at the start of each arm to end of each arm (1 week span)
|
|
General Health Questionnaire-12 General Mental Distress scale
Délai: Difference from measurement at the start of each arm to end of each arm (1 week span)
|
Measured by the standard scoring procedure in each lab visit at the start of the week.
Decrease is considered an improvement.
|
Difference from measurement at the start of each arm to end of each arm (1 week span)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Interoceptive confidence
Délai: 1 week (measure difference between start and end of each arm)
|
Self rated confidence in the accuracy of heartbeat count
|
1 week (measure difference between start and end of each arm)
|
|
Interoceptive awareness
Délai: Start of each arm to end of each arm (1 week)
|
Multidimensional Assessment of Interoceptive Awareness -2 total score.
Increase indicates improved interoceptive awareness.
|
Start of each arm to end of each arm (1 week)
|
|
Daily mood
Délai: 1 week (measured each day of the arm)
|
Brief Mood Introspection Scale (BMIS) positive-negative axis measured each day.
Increase indicates increased positive affect.
|
1 week (measured each day of the arm)
|
|
Daily mood variability
Délai: 1 week (measured each day of the arm)
|
Standard deviation of the Brief Mood Introspection Scale (BMIS) positive-negative mood axis across all the days in an arm.
Increase indicates increased emotional variability.
|
1 week (measured each day of the arm)
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Les enquêteurs
- Chercheur principal: Pattie Maes, PhD, Massachusetts Institute of Technology
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
26 juin 2025
Achèvement primaire (Réel)
19 septembre 2025
Achèvement de l'étude (Réel)
19 septembre 2025
Dates d'inscription aux études
Première soumission
23 juillet 2026
Première soumission répondant aux critères de contrôle qualité
8 septembre 2026
Première publication (Réel)
9 septembre 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
9 septembre 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
8 septembre 2026
Dernière vérification
1 septembre 2026
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2502001554
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
OUI
Description du régime IPD
Defidentified individual survey responses and sensHB accuracy data and analysis code
Délai de partage IPD
Available indefinitely beginning March 2026
Critères d'accès au partage IPD
Data are available to the general public.
Data and analysis scripts can be found at https://osf.io/wfexj/overview
and the preregistered analysis plan can be found at https://aspredicted.org/hnyw-cw85.pdf
Type d'informations de prise en charge du partage d'IPD
- SÈVE
- ANALYTIC_CODE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .